Sharda Cropchem Limited (NSE:SHARDACROP)
India
· Delayed Price · Currency is INR | Market Cap | 104.89B |
| Revenue (ttm) | 50.31B |
| Net Income (ttm) | 5.66B |
| Shares Out | 90.22M |
| EPS (ttm) | 62.73 |
| PE Ratio | 18.53 |
| Forward PE | 16.74 |
| Dividend | 12.00 (1.07%) |
| Ex-Dividend Date | Feb 6, 2026 |
| Volume | 303,317 |
| Average Volume | 365,959 |
| Open | 1,124.70 |
| Previous Close | 1,124.70 |
| Day's Range | 1,124.70 - 1,181.85 |
| 52-Week Range | 506.60 - 1,297.00 |
| Beta | 0.60 |
| RSI | 64.31 |
| Earnings Date | May 8, 2026 |
About Sharda Cropchem
Sharda Cropchem Limited, a crop protection chemical company, provides various formulations and generic active ingredients worldwide. It offers agrochemical products, including insecticides, fungicides, herbicides, veterinary drugs, plant growth regulators, fumigants, regulators, rodenticides, metalaxyl, propiconazole, phenthoate, pendimethalin, and dithianon; and biocides. The company also provides conveyor belts, such as textile ply, rough top, steel cord, chevron/pattern, elevator, sidewall, pipe, and PVC/PVG solid woven conveyor belts, as we... [Read more]
Financial Performance
In fiscal year 2025, Sharda Cropchem's revenue was 43.20 billion, an increase of 36.57% compared to the previous year's 31.63 billion. Earnings were 3.04 billion, an increase of 854.67%.
Financial StatementsNews
Sharda Cropchem Ltd (BOM:538666) Q3 2026 Earnings Call Highlights: Robust Revenue Growth and ...
Sharda Cropchem Ltd (BOM:538666) Q3 2026 Earnings Call Highlights: Robust Revenue Growth and Strategic Dividends Amid Challenges
Q3 2026 Sharda Cropchem Ltd Earnings Call Transcript
Q3 2026 Sharda Cropchem Ltd Earnings Call Transcript
Sharda Cropchem Transcript: Q3 25/26
Q3 and nine-month results showed record PAT, 39% revenue growth in Q3, and strong margin expansion, with Europe and Latin America driving volumes. Guidance remains robust for Q4 and FY 2027, with sustainable margins and continued high CapEx, while the company remains net debt-free and increases dividends.
Sharda Cropchem Ltd (BOM:538666) Q2 2026 Earnings Call Highlights: Robust Agrochemical Growth ...
Sharda Cropchem Ltd (BOM:538666) Q2 2026 Earnings Call Highlights: Robust Agrochemical Growth and Improved Margins
Q2 2026 Sharda Cropchem Ltd Earnings Call Transcript
Q2 2026 Sharda Cropchem Ltd Earnings Call Transcript
Q1 2026 Sharda Cropchem Ltd Earnings Call Transcript
Q1 2026 Sharda Cropchem Ltd Earnings Call Transcript
Q4 2025 Sharda Cropchem Ltd Earnings Call Transcript
Q4 2025 Sharda Cropchem Ltd Earnings Call Transcript
Sharda Cropchem Transcript: Q2 25/26
Q2 FY26 saw 20% revenue growth and 35% volume growth, with gross margins up 690 bps to 34.5% and PAT up 75% year-on-year. Management expects strong H2 performance, maintaining EBITDA margin guidance of 15%-18% and robust cash reserves.
Sharda Cropchem shares jump 5% today – Know More
Shares of Sharda Cropchem Ltd surged 4.60% to ₹1,020 on Tuesday, climbing nearly 5% intraday from the previous close of ₹975.10. The stock saw a sharp rally in afternoon trade, making it one of the no...
Sharda Cropchem Transcript: Q1 25/26
Q1 FY26 saw 25% revenue growth, 67% EBITDA growth, and 424% PAT growth, led by strong European demand, margin expansion, and forex gains. Management expects 15% revenue growth and 15%-18% EBITDA margin for FY26, with robust cash reserves and increased CapEx planned.
Why are Sharda Cropchem shares up over 6% today? Explained
Shares of Sharda Cropchem rose sharply by 6.06% to Rs 963.85 in Wednesday’s trade after the company reported strong financial results for the quarter ended June 30, 2025. The stock gained Rs 55.10 fro...
Sharda Cropchem Q1 results: Revenue up 26% YoY to Rs 958 crore, net profit jumps over 424%
Sharda Cropchem reported its Q1 Results, showcasing a sharp turnaround in profitability and healthy growth in revenue. The company posted a net profit of Rs 143 crore for the quarter ended June 30, 20...
Sharda Cropchem Transcript: Q4 24/25
Q4 and FY25 saw robust revenue and volume growth, especially in agrochemicals, with improved margins and profitability. Management expects 10%-15% growth and margin expansion in FY26, supported by price recovery and strong demand, particularly in Europe and NAFTA.
Q3 2025 Sharda Cropchem Ltd Earnings Call Transcript
Q3 2025 Sharda Cropchem Ltd Earnings Call Transcript
Sharda Cropchem Transcript: Q3 24/25
Q3 FY25 saw a 47% revenue increase and 232% EBITDA growth, driven by strong volume gains and margin expansion. Management expects continued high growth and stable margins, with FY25 revenue projected near INR 4,000 crores and robust cash reserves maintained.
Sharda Cropchem shares surge 4.5% ahead of Q2 results
Sharda Cropchem shares surged by 4.5% today, trading at ₹781.05, ahead of its Q2 FY25 financial results announcement. The stock opened at ₹735.00 and reached an intraday high of ₹784.00, reflecting st...
Sharda Cropchem Transcript: Q2 24/25
Revenue grew 34% year-on-year in Q2 FY2025, led by strong agrochemical performance and margin recovery. Management guides for 15%-18% growth for FY2025, with a robust cash position and improved working capital. NAFTA margins were impacted by high-cost inventory, but overall outlook remains positive.
Q4 2024 Sharda Cropchem Ltd Earnings Call Transcript
Q4 2024 Sharda Cropchem Ltd Earnings Call Transcript
Sharda Cropchem Transcript: Q1 24/25
Q1 FY2025 saw 23% revenue growth and a return to profitability, led by strong agrochemical volumes, especially in Europe. Management maintains 15%-18% growth and margin guidance for FY2025, with gradual price recovery expected as market conditions normalize.